Ruta graveolens

Ruta graveolens, commonly known as rue, common rue or herb-of-grace, is a species of Ruta grown as an ornamental plant and herb. It is native to the Balkan Peninsula. It is now grown throughout the world in gardens, especially for its bluish leaves, and sometimes for its tolerance of hot and dry soil conditions. It is also cultivated as a medicinal herb, as a condiment, and to a lesser extent as an insect repellent.

Description

Ruta graveolens is a perennial herb, which can grow to a height of about 0.8 meters. It has a strong, pungent odor, and a bitter taste. The leaves are bluish-green, and are usually covered with an oily, sticky substance. The flowers are yellow, and are produced in clusters.

Cultivation

Ruta graveolens is a hardy plant that prefers well-drained soil and full sun. It can tolerate drought and poor soil conditions. It is usually propagated by seeds, but can also be propagated by cuttings. It is often used in gardens for its ornamental value, and for its strong, pungent odor which can deter insects.

Uses

Ruta graveolens has been used in traditional medicine for its purported health benefits. It has been used as a treatment for a variety of ailments, including digestive disorders, respiratory problems, and menstrual disorders. However, there is limited scientific evidence to support these uses.

In addition to its medicinal uses, Ruta graveolens is also used as a condiment in some cuisines. The leaves are used to flavor foods, and the seeds are used as a spice. The plant is also sometimes used as an insect repellent.

Toxicity

Ruta graveolens contains a number of potentially toxic compounds, including furanocoumarins and alkaloids. These compounds can cause skin irritation, and can be toxic if ingested in large amounts. The plant is also known to be toxic to cats and dogs.

See also

• List of poisonous plants
• Medicinal plants

External links

• Ruta graveolens at PubMed

Ruta graveolens Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.